Journal for ImmunoTherapy of Cancer (Nov 2020)

109 Dominant-negative TGFβ receptor 2 enhances GPC3-targeting CAR-T cell efficacy against hepatocellular carcinoma

Michael Overstreet,
Eric Tu

Affiliations

Michael Overstreet: AstrZeneca, Gaithersburg, MD, USA
Eric Tu: AstrZeneca, Gaithersburg, MD, USA

DOI: https://doi.org/10.1136/jitc-2020-SITC2020.0109
Journal volume & issue: Vol. 8, no. Suppl 3

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal